224 related articles for article (PubMed ID: 23377396)
1. Mycophenolate mofetil as a first-line steroid-sparing agent in the treatment of pemphigus vulgaris.
Vyas N; Patel NS; Cohen GF
J Drugs Dermatol; 2013 Feb; 12(2):210-6. PubMed ID: 23377396
[TBL] [Abstract][Full Text] [Related]
2. Treatment of pemphigus vulgaris with mycophenolate mofetil as a steroid-sparing agent.
Esmaili N; Chams-Davatchi C; Valikhani M; Farshidfar F; Parvaneh N; Tamizifar B
Eur J Dermatol; 2008; 18(2):159-64. PubMed ID: 18424375
[TBL] [Abstract][Full Text] [Related]
3. Mycophenolate mofetil and enteric-coated mycophenolate sodium in the treatment of pemphigus vulgaris and pemphigus foliaceus.
Doukaki S; Platamone A; Alaimo R; Bongiorno MR
J Dermatolog Treat; 2015 Feb; 26(1):67-72. PubMed ID: 24521072
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of mycophenolate mofetil as a steroid-sparing agent in pemphigus: a randomized, prospective study.
Ioannides D; Apalla Z; Lazaridou E; Rigopoulos D
J Eur Acad Dermatol Venereol; 2012 Jul; 26(7):855-60. PubMed ID: 21752101
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolate mofetil as adjuvant in pemphigus vulgaris.
Sarma N; Ghosh S
Indian J Dermatol Venereol Leprol; 2007; 73(5):348-50. PubMed ID: 17921620
[TBL] [Abstract][Full Text] [Related]
6. Red blood cell anemia in a patient with pemphigus vulgaris induced by the use of mycophenolate mofetil and prednisone.
Scheinfeld N
J Dermatolog Treat; 2007; 18(4):243-5. PubMed ID: 17671884
[TBL] [Abstract][Full Text] [Related]
7. Enteric-coated mycophenolate sodium as a steroid-sparing agent in pemphigus treatment: a retrospective study.
De Simone C; Caldarola G; Perino F; Venier A; Guerriero G
Dermatol Ther; 2012; 25(2):219-22. PubMed ID: 22741942
[TBL] [Abstract][Full Text] [Related]
8. Treating pemphigus vulgaris with prednisone and mycophenolate mofetil: a multicenter, randomized, placebo-controlled trial.
Beissert S; Mimouni D; Kanwar AJ; Solomons N; Kalia V; Anhalt GJ
J Invest Dermatol; 2010 Aug; 130(8):2041-8. PubMed ID: 20410913
[TBL] [Abstract][Full Text] [Related]
9. Treatment of pemphigus vulgaris and pemphigus foliaceus with mycophenolate mofetil.
Mimouni D; Anhalt GJ; Cummins DL; Kouba DJ; Thorne JE; Nousari HC
Arch Dermatol; 2003 Jun; 139(6):739-42. PubMed ID: 12810504
[TBL] [Abstract][Full Text] [Related]
10. An evaluation of the usefulness of mycophenolate mofetil in pemphigus.
Powell AM; Albert S; Al Fares S; Harman KE; Setterfield J; Bhogal B; Black MM
Br J Dermatol; 2003 Jul; 149(1):138-45. PubMed ID: 12890207
[TBL] [Abstract][Full Text] [Related]
11. Images in emergency medicine. Pemphigus vulgaris.
Ahlers KM; Seupaul RA
Ann Emerg Med; 2006 Apr; 47(4):395, 402. PubMed ID: 16546628
[No Abstract] [Full Text] [Related]
12. Treatment outcomes in a cohort of patients with mucosal-predominant pemphigus vulgaris.
Ojaimi S; O'Connor K; Lin MW; Schifter M; Fulcher DA
Intern Med J; 2015 Mar; 45(3):284-92. PubMed ID: 25534017
[TBL] [Abstract][Full Text] [Related]
13. Case reports: nodular vasculitis responsive to mycophenolate mofetil.
Taverna JA; Radfar A; Pentland A; Poggioli G; Demierre MF
J Drugs Dermatol; 2006; 5(10):992-3. PubMed ID: 17373149
[TBL] [Abstract][Full Text] [Related]
14. Mycophenolate mofetil for the treatment of scleritis.
Sen HN; Suhler EB; Al-Khatib SQ; Djalilian AR; Nussenblatt RB; Buggage RR
Ophthalmology; 2003 Sep; 110(9):1750-5. PubMed ID: 13129873
[TBL] [Abstract][Full Text] [Related]
15. Mycophenolate mofetil: a new therapeutic option in the treatment of blistering autoimmune diseases.
Grundmann-Kollmann M; Korting HC; Behrens S; Kaskel P; Leiter U; Krähn G; Kerscher M; Peter RU
J Am Acad Dermatol; 1999 Jun; 40(6 Pt 1):957-60. PubMed ID: 10365927
[TBL] [Abstract][Full Text] [Related]
16. Treatment of refractory blistering autoimmune diseases with mycophenolic acid.
Marzano AV; Dassoni F; Caputo R
J Dermatolog Treat; 2006; 17(6):370-6. PubMed ID: 17853312
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment with mycophenolate mofetil of four Japanese patients with pemphigus vulgaris.
Koga H; Ishii N; Hamada T; Karashima T; Nakama T; Yasumoto S; Hashimoto T
Eur J Dermatol; 2010; 20(4):472-5. PubMed ID: 20406724
[TBL] [Abstract][Full Text] [Related]
18. [IgA pemphigus. Successful treatment with mycophenolate mofetil].
Burchardt T; Büchau A; Ruzicka T; Megahed M
Hautarzt; 2004 Apr; 55(4):387-9. PubMed ID: 15021936
[TBL] [Abstract][Full Text] [Related]
19. [Open trial of mycophenolate mofetil in the treatment of resistant pemphigus vulgaris].
Chams-Davatchi C; Nonahal Azar R; Daneshpazooh M; Valikhani M; Hallaji Z; Barzegari M; Firouz AR; Zakeri M
Ann Dermatol Venereol; 2002 Jan; 129(1 Pt 1):23-5. PubMed ID: 11937925
[TBL] [Abstract][Full Text] [Related]
20. Treatment of pyoderma gangrenosum with mycophenolate mofetil as a steroid-sparing agent.
Li J; Kelly R
J Am Acad Dermatol; 2013 Oct; 69(4):565-9. PubMed ID: 23850090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
